CIK 0001817713
- Large accelerated filer
Janux Therapeutics, Inc.
Sign in to watch- Ticker
- JANX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822289112
- Phone
- +1 858-751-4493
- Business address
- 10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 38 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-27 | Avalon Ventures XI, L.P. 10% owner | Option exercise · Stock Option (right to buy) | −234 | 7,839 | ||
| 2024-09-27 | Meyer Andrew Hollman Chief Business Officer | Option exercise | +50,000 | $4.21 | $211K | 117,592 |
| 2024-09-27 | Meyer Andrew Hollman Chief Business Officer | Sale | −50,000 | $45.96 | $2.3M | 67,592 |
| 2024-09-27 | Meyer Andrew Hollman Chief Business Officer | Option exercise · Stock Option (right to buy) | −50,000 | 100,667 | ||
| 2024-09-27 | DiRaimondo Thomas Chief Scientific Officer | Sale 10b5-1 | −4,325 | $46.21 | $200K | 98,613 |
| 2024-09-27 | DiRaimondo Thomas Chief Scientific Officer | Sale 10b5-1 | −675 | $47.22 | $32K | 97,938 |
| 2024-09-27 | Campbell David Alan President and CEO | Sale 10b5-1 | −18,957 | $46.09 | $874K | 313,097 |
| 2024-09-27 | Campbell David Alan President and CEO | Sale 10b5-1 | −5,248 | $46.86 | $246K | 307,849 |
| 2024-09-27 | Campbell David Alan President and CEO | Sale 10b5-1 | −795 | $47.84 | $38K | 307,054 |
| 2024-09-26 | Avalon Ventures XI, L.P. 10% owner | Sale | −49,497 | $46.78 | $2.3M | 2,909,678 |
| 2024-09-26 | Avalon Ventures XI, L.P. 10% owner | Sale | −9,592 | $46.78 | $449K | 563,635 |
| 2024-09-26 | Avalon Ventures XI, L.P. 10% owner | Sale | −50,539 | $46.78 | $2.4M | 2,970,875 |
| 2024-09-26 | Avalon Ventures XI, L.P. 10% owner | Sale | −40,803 | $47.77 | $1.9M | 2,868,875 |
| 2024-09-26 | Avalon Ventures XI, L.P. 10% owner | Sale | −7,908 | $47.77 | $378K | 555,727 |
| 2024-09-26 | Avalon Ventures XI, L.P. 10% owner | Sale | −41,661 | $47.77 | $2.0M | 2,929,214 |
| 2024-09-13 | Lichter Jay 10% owner | Option exercise | +1,868 | $17.00 | $32K | 8,868 |
| 2024-09-13 | Lichter Jay 10% owner | Option exercise | +778 | $10.73 | $8K | 9,646 |
| 2024-09-13 | Lichter Jay 10% owner | Option exercise | +778 | $13.22 | $10K | 10,424 |
| 2024-09-13 | Lichter Jay 10% owner | Option exercise | +391 | $39.80 | $16K | 10,815 |
| 2024-09-13 | Lichter Jay 10% owner | Sale | −3,815 | $46.68 | $178K | 7,000 |
Page 10 of 15 · 294 trades